Clinical trial
Prazosin as a Novel Treatment for Smoking Cessation
NCT01642433 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prazosin as a Novel Treatment for Smoking Cessation
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2012
- Completion date
- September 30, 2013
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nicotine dependence